已收盘 05-08 16:00:00 美东时间
+0.465
+0.73%
Outlook Therapeutics files FDA dispute on ONS-5010 after CRL citing effectiveness concerns; meeting with agency official set for April 2026.
04-08 02:11
Fidelity Dividend ETF for Rising Rates (NYSEARCA:FDRR) declared $0.28/share quarterly dividend. Payable Sept. 24; for shareholders of record Sept. 20; ex-div Sept. 20. See FDRR Dividend Scorecard, Yie...
2024-09-24 00:41